Sydney Cancer Centre

What Sydney Cancer Centre does

Sydney Cancer Centre, operating as Chris O'Brien Lifehouse, is a not-for-profit specialist cancer hospital established in 2016 in Camperdown, NSW, Australia. The purpose-built facility is located at 119-143 Missenden Road within the Camperdown-Ultimo health and education precinct, adjacent to Royal Prince Alfred Hospital, and operates under the Sydney Local Health District (NSW Health) with an academic affiliation to the University of Sydney. The hospital employs approximately 1,200 staff across clinical, nursing, research, and support functions and delivers integrated cancer care across 12+ specialties including breast, bowel/colorectal, gynaecological, head and neck, lung/mesothelioma, lymphoma/leukaemia/myeloma, neurosurgery, sarcoma, skin/melanoma, upper GI, and urology/prostate cancers.

The hospital's core technology stack combines clinical treatment infrastructure (10 state-of-the-art theatres, an interventional radiology suite, day therapy units, robotic surgery across urology, gynae-oncology, and colorectal surgery, and an Integrated Prosthetics and Reconstruction Lab) with research assets such as the Sydney Brain Tumour Bank and proprietary diagnostics including the PCPro blood test developed by Dr Tahlia Scheinberg. Patient-facing technology includes the COBL Connect mobile app, while supportive care is delivered through the COBL LivingRoom integrative oncology program and the Arterie art-in-healthcare initiative.

The business model blends public funding (Medicare and NSW Health), private healthcare billing (private health insurance, self-pay, workers' compensation), philanthropic donations and fundraising, research grants (including a $5.9 million Australian Government commitment for the Richard Scolyer Chair in Brain Cancer Research in 2026), and clinical trial revenue. GTM is healthcare-professional-led, with patients referred by GPs and specialists, supplemented by self-referrals for certain services and telehealth pathways for regional/rural patients. The hospital maintains both public and private patient beds, serves the New South Wales market primarily, and has won multiple industry awards including the 2024 Australian Private Hospitals Association (APHA) recognition.

Name

Sydney Cancer Centre

Legal name

Chris O'Brien Lifehouse

Website

https://sydneycancer.com.au

Company type

Private

Operating status

Operating

Headcount range

11–50 employees

Short description

Chris O'Brien Lifehouse is a not-for-profit specialist cancer hospital in Camperdown, Sydney, delivering integrated cancer care across 12+ specialties with ~1,200 staff, operating under NSW Health and affiliated with the University of Sydney.

Ownership category

akta.pro rank

Product category

Specialist Cancer Hospital Services

NAICS

Specialty (except Psychiatric and Substance Abuse) Hospitals (6223), Offices of Physicians (except Mental Health Specialists) (621111)

SIC

Services-Hospitals (8060), Services-Specialty Outpatient Facilities, Nec (8093)

akta.pro primary industry

Oncology & Cancer Specialty Hospitals (HLAFAHAC)

akta.pro secondary industry

Hospital-Integrated Cancer Centers (Acute Oncology Programs) (HLAFAAAM)

Keywords

• Cancer treatment services
• Oncology hospital care
• Radiation oncology
• Surgical oncology
• Supportive cancer care

Headquarters

HQ city

Camperdown

HQ country

Australia

HQ region

Oceania

Offices1 record

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

1. Public Healthcare Services: Government-funded healthcare services through Medicare and public hospital funding arrangements with NSW Health
2. Private Healthcare Services: Private patient services billed through private health insurance, self-pay, or workers compensation arrangements. The hospital has both public and private patient beds.
3. Graduate Nurse Program: Two-year structured program for newly registered nurses, providing employment and training opportunities
4. Donations and Fundraising: Philanthropic donations, fundraising events, bequests, corporate partnerships, and special occasion giving programs
5. Clinical Trials: Research collaborations and clinical trial participation generating research funding and grant revenue

Go-to-market motion1 record

Distribution channels5 records

Marketing channels9 records

Core offering

Chris O'Brien Lifehouse is a specialist not-for-profit cancer hospital that provides integrated cancer diagnosis, treatment, and supportive care services across 12+ cancer specialties, including surgery, radiation oncology, chemotherapy, medical oncology, interventional oncology, and allied health, delivered under one roof at its Camperdown facility. The hospital also operates clinical trials, a research institute, and supportive care programs such as the COBL LivingRoom integrative oncology service.

Differentiator

Problem solved

Functional benefit

Brands

• COBL Research Institute: The research institute of Chris O'Brien Lifehouse focused on cancer research.
• COBL Connect App
• COBL LivingRoom

Products and services

• Surgical Oncology Services Surgical cancer treatment across multiple specialties including breast, bowel/colorectal, head and neck, gynaecological, urology, and sarcoma, delivered through 10 state-of-the-art theatres with robotic surgery capabilities and an integrated prosthetics and reconstruction lab. For cancer patients requiring surgical intervention.
• Radiation Oncology Radiation therapy services for cancer patients, delivered as part of the integrated cancer care model at the purpose-built hospital facility.
• Medical Oncology Medical oncology services including chemotherapy and systemic therapy delivered through day therapy units and outpatient clinics for cancer patients not requiring overnight admission.
• Interventional Oncology Specialized interventional radiology services for cancer diagnosis and treatment, delivered through a dedicated interventional radiology suite and procedure room.
• Specialist Cancer Clinics Specialist outpatient clinics covering head and neck, breast, rapid access endoscopy, priority access prostate cancer assessment, rapid access hysteroscopy, gestational trophoblastic disease, skin and melanoma, and outpatient pain — for cancer diagnosis, treatment, and follow-up care.
• Supportive Care (COBL LivingRoom) Integrative oncology and supportive care services through the COBL LivingRoom program, addressing survivorship, allied health, spiritual care, and holistic patient needs throughout the cancer care journey.
• Clinical Trials Program Clinical trials program operated through the COBL Research Institute, providing patients with access to investigational therapies and research collaborations across multiple cancer types.
• Graduate Nurse Program Two-year structured graduate program for newly registered nurses, providing employment and specialist oncology training opportunities at the hospital.
• Pharmacy Services Specialist oncology pharmacy services supporting cancer treatment delivery, including patient medication management and consumer partnership programs.
• Allied Health Services Allied health services integrated into the cancer care delivery model, including physiotherapy, dietetics, and psychosocial support for cancer patients.

Quantifiable outcome

• Above NSW average survival rates for cancer treatment
• +1 more outcomes

Named customers4 records

Segments4 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature6 records

Partnerships

Nine partnerships are on record, tiered core, major and minor.

• University of SydneycoreStrategic or Co-development PartnerAcademic affiliation with University of Sydney for medical education, research collaboration, and clinical training. Medical students, oncology trainees, and PhD students receive training and supervision at Lifehouse. Research collaborations advance cancer treatment and care.
• NSW Health / Sydney Local Health DistrictcoreStrategic or Co-development PartnerPublic hospital affiliation through NSW Health. Lifehouse operates as a not-for-profit specialist cancer hospital within the Sydney Local Health District, with collaboration with Royal Prince Alfred Hospital for complex cases.
• Royal Prince Alfred HospitalcoreStrategic or Co-development PartnerAdjacent major teaching hospital in the Camperdown-Ultimo health precinct. Collaborative relationship for complex case referrals, shared expertise, and integrated patient care.
• ANZUP (Australian and New Zealand Urogenital and Prostate Cancer Trials Group)majorStrategic or Co-development PartnerDr Tahlia Scheinberg serves as study co-chair of the DARO-LIPID clinical trial, a nationwide ANZUP-led study targeting patients with aggressive prostate cancer no longer responding to hormone therapy.
• ANZGOG (Australia New Zealand Gynaecological Oncology Group)majorStrategic or Co-development PartnerProfessional membership and collaboration in clinical trials for gynaecological cancers. Lifehouse specialists participate in ANZGOG research initiatives and clinical trial programs.
• Institute for GlycomicsminorStrategic or Co-development PartnerResearch collaboration on glycomics cancer research. Patients from Chris O'Brien Lifehouse provide samples sent to the institute for analysis as part of new direction in cancer research.
• SmartSalaryminorOthersSalary packaging provider for staff benefits. Employees can access salary packaging to lower taxable income and increase take-home pay, with benefits including vehicle leasing and expense packaging.
• Fitness PassportminorOthersDiscounted workplace health and fitness program available to employees and their families, providing unlimited access to gyms, pools, and fitness centres.
• Sydney Neurobionics Collaboration (SyNC)minorStrategic or Co-development PartnerCollaboration co-founded by Clinical A/Prof Joe Dusseldorp to leverage technological advances in neuromotor disorders, combining clinical and biomedical engineering expertise.

Scale indicators6 records

Recent moves7 records

Expansion highlights6 records

Broad incumbents

• Prince of Wales Hospital: Major public teaching hospital in Sydney with a dedicated cancer services unit. Overlaps with Lifehouse across several cancer specialties and competes for public and private oncology referrals in NSW.
• Royal Marsden Hospital: UK's leading specialist cancer hospital, operating as a charitable foundation within the NHS. Comparable in its specialist-only cancer focus, research integration, and charitable funding model.
• Sydney Adventist Hospital: Large private not-for-profit hospital in Sydney offering oncology services including surgery, chemotherapy, and radiation oncology. Competes with Lifehouse for private insured cancer patients in the Sydney metropolitan area.
• Royal Prince Alfred Hospital: Adjacent major public teaching hospital within Sydney Local Health District and a close partner of Lifehouse. Provides overlapping general and specialist cancer services, making it a referrer and a competitor for complex cancer cases.
• MD Anderson Cancer Center: Large US not-for-profit specialty cancer hospital and research centre. Comparable in its integrated care-under-one-roof model and translational research orientation, providing international scale benchmarking.
• Memorial Sloan Kettering Cancer Center: Global benchmark not-for-profit specialist cancer centre with integrated research, clinical trials, and proprietary diagnostics. Represents the gold-standard model Lifehouse's research and clinical ambitions are positioned against internationally.
• Westmead Hospital Cancer Centre: Major western Sydney public hospital with oncology services serving a large catchment. Competes with Lifehouse for regional and western Sydney patient referrals and clinical trial participation.

Direct peers

• Peter MacCallum Cancer Centre: Australia's largest dedicated cancer hospital, based in Melbourne. Operates as a not-for-profit specialist cancer centre with integrated research and clinical trials, directly comparable in mission, scale, and model to Chris O'Brien Lifehouse.

Regional players

• Royal Brisbane and Women's Hospital: Large Queensland public teaching hospital with comprehensive cancer services. Comparable specialist cancer capability but serves a different Australian state, making it a regional rather than direct competitor.

Others

• Garvan Institute of Medical Research: Sydney-based medical research institute with strong cancer genomics programs. Adjacent rather than competitive — Lifehouse and Garvan collaborate on translational research, and the institute provides a comparable research-funding benchmark.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

• Xx.com/COBLH
• LinkedInlinkedin.com/company/sydney-cancer-centre

Revenue estimate

Valuation estimate

Number of profiles

Profiles12 records

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Sydney Cancer Centre